Digital Library
Close Browse articles from a journal
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             153 results found
no title author magazine year volume issue page(s) type
1 EDITORIAL BOARD
24 S1 p.
article
2 O-15 ABSENCE OF DISEASE REMISSION AS A RISK FACTOR FOR HEPATOCELLULAR CARCINOMA IN PATIENTS WITH AUTOIMMUNE HEPATITIS Vaz, Nayana Fonseca

24 S1 p.
article
3 O-24 A CASE SERIES OF CHLOROQUINE MONOTHERAPY TO INDUCE BIOCHEMICAL REMISSION IN PATIENTS WITH RELAPSED AUTOIMMUNE HEPATITIS Facas, Bianca Pocopetz

24 S1 p.
article
4 O-17 Are macroeconomic and health expenditure indicators correlated with the capacity for liver transplantation in Latin American Countries? THE ALEH Special Interest Group, international Survey 2020 Zapata, Rodrigo

24 S1 p.
article
5 O-26 ASPARTATE AMINOTRANSFERASE, AGE AND D-DIMER IN COVID-19 PATIENTS: A USEFUL PROGNOSTIC MODEL Higuera-de la Tijera, Fátima

24 S1 p.
article
6 O-20 ASSOCIATION BETWEEN UNCOUPLING PROTEIN 3 POLYMORPHISMS AND NONALCOHOLIC FATTY LIVER DISEASE AND METABOLIC SYNDROME Toda-Oti, Karla

24 S1 p.
article
7 O-14 A SYNERGISTIC EFFECT OF PNPLA3 GENE POLYMORPHISM AND INSULIN RESISTANCE INCREASES THE RISK TO NON-ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH POLYCYSTIC OVARY SYNDROME Recuero, Amanda

24 S1 p.
article
8 O-25 BACTERIAL INFECTION ENHANCES THROMBIN GENERATION IN PATIENTS WITH CIRRHOSIS Motta, Marina Pamponet

24 S1 p.
article
9 O-9 COMPARISON OF THE PERFORMANCE OF DIFFERENT SCORES FOR THE PREDICTION OF IN-HOSPITAL MORTALITY IN PATIENTS WITH CIRRHOSIS AND BACTERIAL INFECTIONS Garmendia, Agustina Martinez

24 S1 p.
article
10 O-28 DRUG-INDUCED LIVER INJURY IN LATINAMERICA: First ten years’ experience of the ongoing LATINDILI Network Bessone, Fernando

24 S1 p.
article
11 O-16 EVALUATION OF THE RESPONSE TO TREATMENT OF VITAMIN D DEFICIENCY IN PEDIATRIC PATIENTS WITH CHRONIC LIVER DISEASE da Rocha, Carolina Roos Mariano

24 S1 p.
article
12 O-13 Hepatocellular carcinoma patients are advantage in the Brazilian current liver transplant allocation system. A competing risk analysis. A RETROSPECTIVE STUDY Rodrıguez, Santiago

24 S1 p.
article
13 O-4 IMPACT OF BRIDGE THERAPY FOR HEPATOCELLULAR CARCINOMA IN PATIENTS SUBMITTED TO LIVER TRANSPLANTATION - BRAZILIAN MULTICENTER STUDY Margon, Julia Fadini

24 S1 p.
article
14 O-27 IMPACT OF HBV GENOTYPE F IN THE DIAGNOSIS AND EVOLUTION OF PATIENTS WITH HBEAG-NEGATIVE CHRONIC HBV INFECTION Fainboim, Hugo

24 S1 p.
article
15 O-18 IMPAIRED ANTI-HBV VACCINE RESPONSE IN NON-CIRRHOTIC CHRONIC HCV PATIENTS IS NOT OVERCOME BY DOUBLE DOSE REGIMEN. FOURTH DOSE MAYBE THE ANSWER! Medeiros, Roseane Pôrto

24 S1 p.
article
16 O-19 INCIDENCE, PATTERN OF PRESENTATION AND RISK FACTORS FOR HEPATOCELLULAR CARCINOMA AFTER DIRECT ACTING ANTIVIRAL TREATMENT IN PATIENTS WITH HEPATITIS C VIRUS CIRRHOSIS Porto Medeiros, Roseane

24 S1 p.
article
17 O-22 METABOLIC ASSOCIATED FATTY LIVER DISEASE: A SEVERE LIVER DISEASE Do Vale, Ana Rafaela S.

24 S1 p.
article
18 O-23 METABOLIC ASSOCIATED FATTY LIVER DISEASE CLINICAL PROFILE IN LEAN PATIENTS: CAN IT BE DIFFERENT? Cabral, Andreza Rosa

24 S1 p.
article
19 O-12 MIR-181A AS A BIOMARKER OF FIBROSIS IN NON-ALCOHOLIC FATTY LIVER DISEASE Lima, Rodrigo Vieira Costa

24 S1 p.
article
20 O-6 NON-INVASIVE ASSESSMENT OS HEPATIC FIBROSIS BEFORE AND AFTER HCV CURE AND CORRELATION WITH CLINICAL OUTCOMES Ragazzo, T.G.

24 S1 p.
article
21 OP-4 Current status of Liver transplantation in Latin America: The Latin-American ALEH special interest group, international Survey 2020 Zapata, Rodrigo

24 S1 p.
article
22 OP-1 GUT METATRANSCRIPTOMICS AND METABOLOMICS REVEAL ASSOCIATION OF CYSTEINE AND PURINE METABOLISMS WITH METABOLIC ASSOCIATED FATTY LIVER DISEASE (MAFLD) Mazzini Flavia, Noelia

24 S1 p.
article
23 OP-2 IN VITRO CHARACTERIZATION OF HEPATITIS B VIRUS REPLICATION AND VIRAL ANTIGEN EXPRESSION AMONG GENOTYPES Elizalde, Mercedes

24 S1 p.
article
24 OP-3 LONG-TERM RIFAXIMIN IS SAFE AND ITS RELATED TO LESS FREQUENCY OF COMPLICATIONS LIKE VARICEAL BLEEDING IN CIRRHOTIC PATIENTS Higuera-de-la-Tijera, Fátima

24 S1 p.
article
25 O-7 PREVALENCE, CHARACTERIZATION AND SURVIVAL OF ACUTE-ON-CHRONIC LIVER FAILURE IN A CHILEAN UNIVERSITY HOSPITAL Idalsoaga, Francisco

24 S1 p.
article
26 O-10 PRIMARY BILIARY CHOLANGITIS PATIENTS DIAGNOSED BY DIFFERENT COMBINATIONS OF THE DIAGNOSTIC CRITERIA PRESENT CLINICAL AND LABORATORY PECULIARITIES Cançado, Guilherme G.L.

24 S1 p.
article
27 O-5 PROGNOSTIC IMPORTANCE OF TRANSIENT ELASTOGRAPHY (FIBROSCAN®) FOR MORTALITY AND CARDIOVASCULAR OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES Leite, Nathalie C.

24 S1 p.
article
28 O-11 REMODELING OF IMMUNOLOGICAL BIOMARKERS IN PATIENTS WITH CHRONIC HEPATITIS C TREATED WITH DIRECTACTING ANTIVIRAL THERAPY Ribeiro, Isabela Gomes

24 S1 p.
article
29 O-2 ROLE OF IMMUNE CHECKPOINTS AND ACTIVATED HELPER AND CYTOTOXIC T-CELLS IN DRUG-INDUCED LIVER INJURY (DILI) Cueto-Sanchez, Alejandro

24 S1 p.
article
30 O-21 SOLUBLE CD163 PERFORMANCE AS A NON-INVASIVE BIOMARKER OF DIFFERENT LIVER CONDITIONS Victoria, Cairoli

24 S1 p.
article
31 O-8 THE IMPORTANCE OF LYSOSOMAL ACID LIPASE DEFICIENCY IN THE ETIOLOGICAL INVESTIGATION OF CRYPTOGENIC LIVER DISEASE IN ADULTS: A MULTICENTER STUDY Candolo, Aline Coelho Rocha

24 S1 p.
article
32 O-1 THE ROLE OF PNPLA3 AND TM6SF2 POLYMORPHISMS ON LIVER FIBROSIS AND METABOLIC ABNORMALITIES IN BRAZILIAN PATIENTS WITH CHRONIC HEPATITIS C Oliveira, Arthur Ivan N.

24 S1 p.
article
33 O-3 TRENDS IN DECEASED DONOR AND LIVING DONOR LIVER TRANSPLANTATION IN LATIN AMERICAN COUNTRIES DURING A DECADE (2010-2019) . THE ALEH SPECIAL INTEREST GROUP, INTERNATIONAL SURVEY 2020 Zapata, Rodrigo

24 S1 p.
article
34 P-36 ACCURACY OF PROGNOSTIC SCORES IN PREDICTION OF MORTALITY IN CIRRHOTIC PATIENTS ADMITTED TO THE INTENSIVE CARE UNIT Silva, Pedro

24 S1 p.
article
35 P-4 ALBUMIN LEVELS HAVE STRONGASSOCIATION WITH MORTALITY IN COVID-19 INFECTED PATIENS Vázquez-Medina, Martín Uriel

24 S1 p.
article
36 P-112 ALPHA-FETOPROTEIN AS A PROGNOSTIC FACTOR IN PATIENTS WITH HEPATOCELLULAR CARCINOMA SUBMITTED TO LIVER TRANSPLANTATION – BRAZILIAN MULTICENTER STUDY Lopes Chagas, Aline

24 S1 p.
article
37 P-27 ALTERATION IN LIVER FUNCTION TESTS AMONG PATIENTS HOSPITALIZED FOR COVID-19: A MULTICENTRIC STUDY IN PERU Marín Dueñas, Ivania

24 S1 p.
article
38 P-81 ALTERNATIVE THERAPIES FOR DIFFICULT-TO-TREAT AUTOIMMUNE HEPATITIS: AN EXPERIENCE OF THREE BRAZILIAN REFERRAL CENTERS Cardozo, Ana Julia

24 S1 p.
article
39 P-22 ANALYSIS OF FEATURES ASSOCIATED WITH DIFFICULTY IN SCREENING AND EARLY DIAGNOSING HEPATOCELLULAR CARCINOMA IN RISK PATIENTS Loureiro Lopes, João Eugênio

24 S1 p.
article
40 P-19 ANTI-RIBOSOMAL P (ANTI-P) ANTIBODIES IN AUTOIMMUNE HEPATITIS PATIENTS Gallo, Clarisse de Almeida

24 S1 p.
article
41 P-89 ASSESSMENT OF HEPATIC FIBROSIS IN TYPE 2 DIABETIC PATIENTS: A CROSS SECTIONAL ANALYSIS Rodrigo, Mincis

24 S1 p.
article
42 P-121 ASSESSMENT OF THE ANTERIOR AND POSTERIOR ATTENTIONAL NETWORKS IN PATIENTS WITH MINIMAL HEPATIC ENCEPHALOPATHY Santana, Daniel

24 S1 p.
article
43 P-98 BIOCHEMICAL MAKERS AMONG CHRONIC LIVER DISEASE PATIENTS ACCORDING COVID-19 INFECTION: A FOLLOW-UP STUDY da Silva, Lucas Lima

24 S1 p.
article
44 P-28 BODY COMPOSITION MEASUREMENT AND NONALCOHOLIC FATTY LIVER DISEASE Nogueira Saad, Maria Auxiliadora

24 S1 p.
article
45 P-21 BONE MASS, VITAMIN D LEVELS AND NONALCOHOLIC FATTY FIVER DISEASE Petrucio, Clara

24 S1 p.
article
46 P-79 CHOOSING WISELY IN VIRAL HEPATITIS: RECOMMENDATIONS FROM THE BRAZILIAN SOCIETY OF HEPATOLOGY Villela-Nogueira, Cristiane A.

24 S1 p.
article
47 P-103 CLINICAL AND EPIDEMIOLOGICAL CHARACTERISTICS OF HEPATOCELLULAR CARCINOMA ANALYSIS OF A TERTIARY REFERRAL CENTER IN BRAZIL Yuami, M.K.

24 S1 p.
article
48 P-7 CLINICAL AND HISTOPATHOLOGICAL FEATURES OF THIRTY-FIVE OBLITERATIVE PORTAL VENOPATHY PATIENTS AND POTENTIAL ROLE OF XENOBIOTICS Nunes, Vinicius Santos

24 S1 p.
article
49 P-29 CLINICAL FEATURES OF PRIMARY BILIARY CHOLANGITIS IN BRAZIL Cançado, Guilherme G.L.

24 S1 p.
article
50 P-72 CLINICAL PROFILE OF PATIENTS SUBJECTED TO ENDOSCOPIC LIGATION OF ESOPHAGEAL VARICES IN A REFERENCE HOSPITAL IN THE DOMINICAN REPUBLIC Duran Aileen, Mateo

24 S1 p.
article
51 P-97 COLOMBIAN EXPERIENCE IN THE MANAGEMENT OF PATIENTS WITH SARS-CoV-2 INFECTION AND LIVER TRANSPLANTATION Gomez Aldana, Andres

24 S1 p.
article
52 P-13 COMPARISON OFF DIFFERENT PROGNOSTIC SCORES FOR PATIENTS WITH CIRRHOSIS HOSPITALIZED WITH SARS – COV 2 INFECTION Mendizabal, Manuel

24 S1 p.
article
53 P-58 CONCORDANCE BETWEEN ECOGRAPHY AND THE CONTINUOUS ATTENUATION PARAMETER (CAP) BY TRANSIENT ELASTOGRAPHY FOR THE DIAGNOSIS OF LIVER STEATOSIS Rozas, Juan Francisco

24 S1 p.
article
54 P-65 CONCORDANCE OF FIB-4 WITH TRANSITION ELASTOGRAPHY IN THE DIAGNOSIS OF ADVANCED LIVER FIBROSIS Rozas, Juan Francisco

24 S1 p.
article
55 P-108 CORONAVIRUS DISEASE (COVID-19) IN LIVER TRANSPLANT PATIENTS: A SINGLE CENTER EXPERIENCE IN BOGOTÁ COLOMBIA Gutiérrez, Margarita

24 S1 p.
article
56 P-66 COULD PROTEIN CONTENT OF URINARY EXTRACELLULAR VESICLES BE USEFUL TO DETECT CIRRHOSIS IN ALCOHOLIC LIVER DISEASE? Gonzalez, E.

24 S1 p.
article
57 P-113 COVID 19 AND CIRRHOSIS, A DEADLY COMBINATION. WHAT HAPPENS IN ECUADOR? Guaranda, Manuel

24 S1 p.
article
58 P-49 COVID 19-PANDEMIC AND OUTCOMES IN DECOMPENSATE CIRRHOSIS-10 MONTHS REVIEW Pollo-Flores, Priscila

24 S1 p.
article
59 P-106 COVID-19 PRESENTATION AND OUTCOMES IN 33 PATIENTS WITH AUTOIMMUNE HEPATITIS Fadini Margon, Julia

24 S1 p.
article
60 P-74 ELEVATED CALPROTECTIN LEVELS ARE ASSOCIATED WITH MORTALITY IN PATIENTS WITH ACUTE DECOMPENSATION OF CIRRHOSIS Matiollo, Camila

24 S1 p.
article
61 P-107 EPIDEMIOLOGICAL AND CLINICAL PROFILE OF AUTOIMMUNE HEPATITIS IN A BRAZILIAN TERTIARY HOSPITAL Toledo Turano, Camila

24 S1 p.
article
62 P-46 EPIDEMIOLOGICAL PROFILE AND CLINICAL OUTCOMES OF PATIENTS INTOXICATED WITH ACETAMINOPHEN FOR SUICIDAL PURPOSES AT HOSPITAL SAN VICENTE FUNDACIÓN RIONEGRO: A CASE SERIES Vasquez, Daniel

24 S1 p.
article
63 P-14 EVALUATION AND SELECTION OF CANDIDATES FOR LIVER TRANSPLANTATION: AN ECONOMIC PERSPECTIVE. RETROSPECTIVE STUDY Rodríguez, Santiago

24 S1 p.
article
64 P-71 EVALUATION OF ANXIETY AND DEPRESSION IN PATIENTS WITH CIRRHOSIS AND THE IMPACT ON THE QUALITY OF LIFE Luis, Pérez Hernández José

24 S1 p.
article
65 P-33 EVALUATION OF CIRCULATING METABOLOME IN THE SEARCH OF POTENTIAL DRUG-INDUCED LIVER INJURY BIOMARKERS Zeo-Sánchez, Daniel E. Di

24 S1 p.
article
66 P-32 EVALUATION OF HEPATIC FIBROSIS THROUGH NON-INVASIVE METHODS IN PATIENTS WITH CHRONIC VIRAL HEPATITIS B AND C de Oliveira Fraga, Felipe José

24 S1 p.
article
67 P-88 EVALUATION OF STEATOSIS AND LIVER FIBROSIS IN PATIENTS WITH PSORIASIS: THE IMPACT OF METHOTREXATE AND METABOLIC FACTORS ON THE SEVERITY OF THE DISEASE Agoglia, Luciana

24 S1 p.
article
68 P-102 EVEROLIMUS IN RENAL DYSFUNCTION IN LIVER TRANSPLANTATION Salinas, Carolina

24 S1 p.
article
69 P-37 EXPERIENCE IN MEXICO WITH DIRECT ACTING ANTIVIRALS AS A TREATMENT FOR HEPATITIS C Pérez Hernández, J.L.

24 S1 p.
article
70 P-39 EXPERIENCE IN THE MANAGEMENT OF REFRACTORY HEPATIC ENCEPHALOPATHY THROUGH ENDOVASCULAR THERAPY Muñoz, Claudia

24 S1 p.
article
71 P-53 FAILURE IN ALL STEPS OF HEPATOCELLULAR CARCINOMA SURVEILLANCE PROCESS IS FREQUENT IN DAILY PRACTICE. Dirchwolf, Melisa

24 S1 p.
article
72 P-68 FREQUENCY AND FACTORS ASSOCIATED WITH ANTIBIOTIC DE-ESCALATION IN PATIENTS WITH CIRRHOSIS AND BACTERIAL INFECTIONS Acevedo, Maria Nelly Gutierrez

24 S1 p.
article
73 P-24 FREQUENCY AND SEVERITY OF LIVER INVOLVEMENT IN PREGNANT WOMEN ADMITTED TO AN INTENSIVE CARE UNIT WITH HYPERTENSIVE DISORDERS OF PREGNANCY Castro, J.

24 S1 p.
article
74 P-111 FREQUENCY OF LIVER STEATOSIS AND FIBROSIS DETERMINED BY FIBROSCAN AND CAP IN A SCREENING PROGRAM Montes Teves, Pedro

24 S1 p.
article
75 P-119 GENETIC VARIABILITY OF HEPATITIS B VIRUS AMONG DIFFERENT PHASES OF CHRONIC INFECTION AND HIV COINFECTION IN BRAZIL Melo Villar, Livia

24 S1 p.
article
76 P-73 HEPATIC CHANGES BY SARS-COV 2 IN PATIENTS OF THE INTENSIVE CARE UNIT OF THE TROPICAL MEDICINE CENTER IN RONDÔNIA Felix Soares, Camylla

24 S1 p.
article
77 P-2 HEPATIC STEATOSIS AMONG PEOPLE LIVING WITH HIV IN SOUTHERN BRAZIL: PREVALENCE AND RISK FACTORS Ferri-Pezzini, Marina

24 S1 p.
article
78 P-127 HEPATITIS A WITH ACALCULOUS CHOLECYSTITIS, PLEURAL EFFUSION, PERICARDIAL EFFUSION AND ASCITIS Mateo, Aileen

24 S1 p.
article
79 P-48 HEPATITIS DELTA: THE MOST SEVERE OF ALL VIRAL HEPATITIS Teixeira Ton, Júlia

24 S1 p.
article
80 P-5 HEPATITIS E VIRUS INFECTION INCREASES THE RISK OF DIABETES AND MORTALITY IN HCV infected patients Zitelli, Patricia Momoyo Yoshimura

24 S1 p.
article
81 P-51 HEPATOCELLULAR CARCINOMA: ONLY EARLY DIAGNOSIS IS NOT ENOUGH Soares Gomes Canedo, Fernanda

24 S1 p.
article
82 P-95 HEPATOXICITY FOR DRUGS AND HERBAL PRODUCTS IN INPATIENTS FROM A UNIVERSITY HOSPITAL, BRAZIL Paranhos, Barbosa Mariana

24 S1 p.
article
83 P-87 HIGH PREVALENCE OF SARS-COV-2 ANTIBODIES IN PREGNANT WOMEN INFECTED WITH VIRAL HEPATITIS IN BRAZIL Calheiros Santos, Alanna

24 S1 p.
article
84 P-47 HISTOPATHOLOGICAL ANALYSIS OF 10-YEAR PROTOCOL LIVER ALLOGRAFT BIOPSY OF ASYMPTOMATIC PEDIATRIC RECIPIENTS FROM A SINGLE BRAZILIAN CENTER Soares, Luciana E.

24 S1 p.
article
85 P-104 IMPACT OF BACTERIAL INFECTIONS IN THE CLINICAL COURSE OF CIRRHOTIC PATIENTS ADMITTED TO THE INTENSIVE CARE UNIT D'Oliveira, Rac

24 S1 p.
article
86 P-101 IMPACT OF COMPLETE AND PREVENTIVE LOCKED–DOWN BEFORE COVID 19 OUTBREAK IN ORGAN PROCUREMENT AND SOLID TRANSPLANTATION IN ARGENTINA: THE WORST HAS NOT YET ARRIVED. Pages, Josefina

24 S1 p.
article
87 P-30 IMPACT OF PUBLIC HEALTH POLICIES ON ALCOHOL-ASSOCIATED LIVER DISEASE IN LATIN AMERICA: AN ECOLOGICAL MULTI-NATIONAL STUDY Díaz Luis, Antonio

24 S1 p.
article
88 P-3 IMPACT OF THE SUSTAINED VIROLOGICAL RESPONSE ON THE GLUCOSE METABOLISM IN PATIENTS WITH HEPATITIS C Benetti, Fabia

24 S1 p.
article
89 P-84 IMPLEMENTATION OF A STEP-BY-STEP STRATEGY BASED ON THE TREATMENT CASCADE TO ELIMINATE HEPATITIS C VIRUS INFECTION IN THE HOSPITAL CENTRAL DE LAS FUERZAS ARMADAS FROM URUGUAY. PRELIMINARY REPORT Otegui, Juan

24 S1 p.
article
90 P-43 INDICATORS OF RESPONSE TO FIRST TRANSARTERIAL CHEMOEMBOLIZATION (TACE) IN HEPATOCELULLAR CARCINOMA Domínguez, Alejandra

24 S1 p.
article
91 P-62 INFECTIONS IN THE FIRST MONTH POST LIVER TRANSPLANTATION IN A TRANSPLANT CENTER IN CHILE Uribe, Gabriel

24 S1 p.
article
92 P-126 INTERPHASE HEPATITIS IN PRIMARY BILIARY CHOLANGITIS, SEVERITY FACTOR AND NO RESPONSE TO URSODEOXICOLIC ACID? Ramírez, Felipe

24 S1 p.
article
93 P-10 LATIN AMERICAN REGISTRY OF CHOLANGIOCARCINOMA: CLINICAL FEATURES, MANAGEMENT AND OUTCOMES da Fonseca, Leonardo G.

24 S1 p.
article
94 P-45 LIVER HEMODYNAMIC AND TRANSJUGULAR LIVER BIOPSY: ROLE IN DIAGNOSTIC AND THERAPEUTIC BEHAVIOR Urzúa, Alvaro

24 S1 p.
article
95 P-57 LIVER STEATOSIS AND STEATOHEPATITIS IN LIVER DISEASES OTHER THAN ALCOHOLIC AND NON-ALCOHOLIC FATTY LIVER Jiménez, Ana

24 S1 p.
article
96 P-122 LIVER TRANSIENT ELASTOGRAPHY (FIBROSCAN). FIRST REPORT OF EXPERIENCE IN ECUADOR Abarca Ruiz, Jaysoom

24 S1 p.
article
97 P-114 LIVER TRANSPLANTATION FOR NON-ALCOHOLIC STEATOHEPATITIS: OUTCOMES IN THE MAIN TRANSPLANT CENTER IN PERU Espinoza, Saúl

24 S1 p.
article
98 P-61 LIVER TRANSPLANTATION IN HEPATOCARCINOMA: SURVIVAL AND RECURRENCE IN TRANSPLANTED PATIENTS WITH HEPATOCARCINOMA García, Daniela

24 S1 p.
article
99 P-59 LIVER TRANSPLANTATION: SIX YEARS EXPERIENCE IN A UNIVERSITY HOSPITAL OF CHILE Chang, Hiru

24 S1 p.
article
100 P-117 LOW PREVALENCE OF HEPATITIS B AND C AMONG PEOPLE LIVING IN POVERTY IN NORTHEAST BRAZIL Melo Villar, Livia

24 S1 p.
article
101 P-56 LOW ROLE OF NON-INVASIVE FIBROSIS ASSESSMENT USING FIB-4 AND APRI IN PATIENTS WITH AUTOIMMUNE HEPATITIS Lamaison, Aline

24 S1 p.
article
102 P-115 MANAGEMENT AND OUTCOME OF LIVER ABCESS AFTER LIVER TRANSPLANTATION: EXPERIENCE OF A SINGLE CENTER IN PERU Montufar, Augudberto

24 S1 p.
article
103 P-86 MELD SCORE AND EARLY EXTUBATION IN THE INTENSIVE CARE UNIT AFTER LIVER TRANSPLANTATION: 20 YEARS EXPERIENCE IN A SINGLE CENTER IN PERU Cerron, Carmen

24 S1 p.
article
104 P-20 METABOLIC ASSOCIATED FATTY LIVER DISEASE: FIBROSIS AND SARCOPENIA FREQUENCIES Pollo Flores, Priscila

24 S1 p.
article
105 P-94 METABOLIC SYNDROME IN PATIENTS WITH CHRONIC HEPATITIS C Menezes, G.B.L.

24 S1 p.
article
106 P-120 NATIONAL SURVEY ON CURRENT PRACTICES TO PREVENT HBV REACTIVATION DURING IMMUNOSUPPRESSION Araujo-Neto, J.M.

24 S1 p.
article
107 P-118 NONINVASIVE PARAMETERS OF PREDICTORS OF ESOPHAGEAL VARICES (EV) IN CHILDREN WITH INTRAHEPATIC PORTAL HYPERTENSION Adam, Marina R.

24 S1 p.
article
108 P-35 NONINVASIVE PREDICTORS OF ESOPHAGEAL VARICES IN PATIENTS WITH HEPATOSPLENIC SCHISTOSOMIASIS MANSONI: MULTICENTER STUDY Nardelli, Mateus Jorge

24 S1 p.
article
109 P-31 NORMAL TRANSAMINASES IN OBESE PATIENTS WITH METABOLIC ASSOCIATED STEATOHEPATITIS Lozano, Adelina

24 S1 p.
article
110 P-34 OUTCOME OF HEPATITIS C TREATMENT WITH DIRECT-ACTING ANTIVIRALS AFTER UNIVERSAL ACCESS TO THERAPY Blanco-Sampascual, S.

24 S1 p.
article
111 P-26 PORTAL VENOUS THROMBOSIS IN TRANSPLANTED CIRRHOTIC PATIENTS AT THE “HOSPITAL CLÍNICO UNIVERSIDAD DE CHILE” Henríquez Auba, V.N.

24 S1 p.
article
112 P-124 POST PARACENTESIS COMPLICATIONS IN PATIENTS WITH DIAGNOSIS OF LIVER CIRRHOSIS Molina, Kevin

24 S1 p.
article
113 P-110 POST-TRANSPLANT OUTCOMES IN PATIENTS WITH HEPATOCELLULAR CARCINOMA SUBMITTED TO DOWN-STAGING – BRAZILIAN MULTICENTER STUDY Fadini Margon, Julia

24 S1 p.
article
114 P-11 POTENTIALLY HEPATOTOXIC DRUGS ARE STILL BEING PRESCRIBED TO LIVER DISEASE PATIENTS UNDER TERTIARY CARE: IT IS TIME TO SAY ENOUGH Dorelo, Rodrigo

24 S1 p.
article
115 P-116 PREGNANCY AFTER LIVER TRANSPLANTATION: OUTCOMES IN PERU Cárdenas Ramírez, Bertha

24 S1 p.
article
116 P-8 PRESERVATION OF THROMBIN GENERATION IN CIRRHOSIS DESPITE ABNORMAL RESULTS OF INTERNATIONAL NORMALIZED RATIO: IMPLICATIONS FOR INVASIVE PROCEDURES Ferreira, Caroline Marcondes

24 S1 p.
article
117 P-18 PREVALENCE AND EPIDEMIOLOGICAL CHARACTERISTICS OF INFECTIONS IN PATIENTS WITH CHRONIC LIVER DISEASE: RETROSPECTIVE ANALYSIS FROM A GENERAL HOSPITAL IN MONTERREY, NUEVO LEON, MEXICO Salinas-Casanova, José Alfredo

24 S1 p.
article
118 P-1 PREVALENCE AND EPIDEMOLOGY OF BACTERIAL INFECTIONS IN PATIENTS WITH ALCOHOLIC HEPATITIS: A RETROSPECTIVE STUDY OF PATIENTS ADMITTED AT THE SAN RAFAEL DE ALAHUELA HOSPITAL, COSTA RICA Ochoa, Alejandra

24 S1 p.
article
119 P-105 PREVALENCE OF ANTIMITOCHONDRIAL ANTIBODIES IN PATIENTS WITH PRIMARY BILE CHOLANGITIS AND ITS OUTCOME IN LIVER TRANSPLANTATION Gomez Aldana, Andres

24 S1 p.
article
120 P-77 PREVALENCE OF HCV INFECTION DETECTED BY RAPID ANTIBODY TEST IN SCREENING CAMPAIGNS IN LIMA AND CALLAO – PERU Diaz Ferrer, Javier

24 S1 p.
article
121 P-50 PREVALENCE OF HEPATITIS AMONG STUDENTS AND HEALTH PROFESSIONALS AT THE FEDERAL UNIVERSITY OF BAHIA Andrade, Jacy

24 S1 p.
article
122 P-91 PREVALENCE OF HEPATITIS C VIRUS INFECTION DETECTED BY RAPID TEST IN A HIGH-RISK POPULATION Teves, Pedro Montes

24 S1 p.
article
123 P-93 PREVALENCE OF HEPATITIS E VIRUS IN DIFFERENT GROUPS OF PATIENTS IN SALVADOR, BA, BRAZIL Lopes, G.

24 S1 p.
article
124 P-99 PREVALENCE OF SARCOPENIA IN PATIENTS WITH LIVER CIRRHOSIS. A CROSS-SECTIONAL STUDY AT TEODORO MALDONADO CARBO HOSPITAL Teran, Zoila

24 S1 p.
article
125 P-123 PROFILE OF NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) X TREATMENT: A NUTROLOGY'S VIEW de Almeida-PHD, Suzana Tyrrasch

24 S1 p.
article
126 P-76 PROGNOSTIC FACTORS FOR SEVERITY AND MORTALITY IN COVID-19: ARE LIVER TESTS IMPORTANT? Pozzobon, Fernanda Manhaes

24 S1 p.
article
127 P-52 PROSPECTIVE COHORT OF PATIENTS WITH LIVER INJURY INDUCED BY DRUGS, HERBS OR DIETARY SUPPLEMENTS Santos Nunes, Vinícius

24 S1 p.
article
128 P-12 QUALITATIVE EVALUATION OF NATURAL PRODUCTS USED BY PATIENTS IN A BRAZILIAN HEPATOTOXICITY AMBULATORY Lopes, Caio Medina

24 S1 p.
article
129 P-55 QUALITY OF LIFE IMPROVES IN PATIENTS WITH OR WITHOUT CIRRHOSIS AFTER HEPATITIS C CURE WITH DIRECT-ACTING ANTIVIRAL AGENTS Garcia Olveira, Lucrecia

24 S1 p.
article
130 P-69 RELATION BETWEEN CLINICAL AND ELASTOGRAPHIC CHARACTERISTICS OF CIRRHOTIC PATIENTS WITH ENDOSCOPIC VARICEAL LIGATION: A SINGLE-CENTER EXPERIENCE IN LIMA, PERU Garavito-Rentería, Jorge

24 S1 p.
article
131 P-83 RELEVANCE OF RENAL CHANGES IN A LARGE SERIES OF SEVERELY OBESE PATIENTS WITH METABOLIC ASSOCIATED FATTY LIVER DISEASE Dias Carvalho, Kellyane

24 S1 p.
article
132 P-125 REX SHUNT IN A DEVELOPING COUNTRY – IS IT POSSIBLE? Dias, Caroline Montagner

24 S1 p.
article
133 P-9 SAFETY AND EFFECTIVENESS OF DIRECT ACTING AGENTS FOR HCV TREATMENT AFTER LIVER TRANSPLANTATION IN RIO DE JANEIRO (BRAZIL) Pinto, L.C.M.

24 S1 p.
article
134 P-23 SEROLOGICAL PROFILE OF HEPATITIS B AND C IN REUMATHOLOGIC PATIENTS IN USE OF IMMUNOSSUPRESSIVE THERAPY Azevedo Solino, Gabriela

24 S1 p.
article
135 P-70 SEROPREVALENCE OF HEPATITIS C VIRUS IN DONORS OF THE BLOOD BANK OF THE GENERAL HOSPITAL OF MEXICO "DR. EDUARDO LICEAGA " A FOUR-YEAR EVALUATION Pérez Hernández, José Luis

24 S1 p.
article
136 P-42 SEROPREVALENCE OF IgG and IgM ANTI-HEV ANTIBODIES USING AN AUTOMATED METHOD: EXPERIENCE OF A UNIVERSITY CENTER Covarrubias, Natalia

24 S1 p.
article
137 P-40 SEVERE AUTOIMMUNE HEPATITIS: CORTICOSTEROID THERAPY OR EARLY ENROLLMENT TO LIVER TRANSPLANTATION Jiménez, Andrea

24 S1 p.
article
138 P-80 SEVERELY OBESE PATIENTS HAD HEPATIC FIBROSIS EVEN WITHOUT METABOLIC SYNDROME Daltro, Carla

24 S1 p.
article
139 P-25 SLOWER FIBROSIS PROGRESSION IN HEPATITIS C HEMOPHILIAC PATIENTS? Bastos, Dauana O.

24 S1 p.
article
140 P-6 SOFOSBUVIR CONTAINING REGIMENS ARE SAFE AND EFFECTIVE IN ADOLESCENTS WITH CHRONIC HEPATITIS C INFECTION Wirth, Stefan

24 S1 p.
article
141 P-54 STUDY OF BACTERIAL INFECTIONS IN 134 HOSPITALIZATIONS OF PATIENTS WITH LIVER CIRRHOSIS Fedatto Beraldo, Rodrigo

24 S1 p.
article
142 P-64 THE ALCOHOL-ASSOCIATED LIVER DISEASE PARADOX IN CHILE: AN ASSESSMENT WITH DATA FROM THE NATIONAL HEALTH SURVEY (ENS 2016-2017) Oneto, Gianfranco

24 S1 p.
article
143 P-44 TRANSARTERIAL CHEMOEMBOLIZATION IN PATIENTS WITH CONTROVERSIAL INDICATION Domínguez, Alejandra

24 S1 p.
article
144 P-63 TRENDS IN HOSPITALIZATION AND MORTALITY IN HOSPITALIZED PATIENTS WITH ALCOHOLIC HEPATITIS IN CHILE Roblero, Juan Pablo

24 S1 p.
article
145 P-41 TRENDS IN HOSPITALIZATION, CHARACTERISTICS AND MORTALITY OF HOSPITALIZED PATIENTS WITH CIRRHOSIS IN CHILE Roblero, Juan Pablo

24 S1 p.
article
146 P-67 ULTRASOUND GUIDED TRANSIENT ELASTOGRAPHY FOR THE DIAGNOSIS AND STAGING OF LIVER FIBROSIS Rozas, Juan Francisco

24 S1 p.
article
147 P-75 UPDATE OF CLINICO-EPIDEMIOLOGICAL CHARACTERISTICS OF PRIMARY BILIAR CHOLANGITIS IN URUGUAY Patricia, Etchandy

24 S1 p.
article
148 P-82 URSODEOXYCHOLIC ACID AND/OR CIPROFIBRATE FOR TREATING PATIENTS WITH PRESUMPTIVE DIAGNOSIS OF LOW PHOSPHOLIPID CHOLELITHIASIS, A CLINICAL SPECTRUM OF PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS TYPE 3 Linahres, Fernanda

24 S1 p.
article
149 P-78 USE OF ARTERIAL CONDUITS IN LIVER TRANSPLANTATION: OUTCOMES IN A SINGLE CENTRE IN PERU Solar Peche, Alfonso

24 S1 p.
article
150 P-85 USE OF LOW DOSES OF GENERIC TACROLIMUS AND THERAPEUTIC LEVELS IN LIVER TRANSPLANT PATIENTS: RESULTS FROM A SINGLE CENTER IN PERU Padilla-Machaca, P. Martín

24 S1 p.
article
151 P-38 UTILITY OF PUPILLARY REACTIVITY IN THE FUNCTIONAL ASSESSMENT OF THE AUTONOMOUS NERVOUS SYSTEM IN PATIENTS WITH CHRONIC LIVER DISEASE: PRELIMINARY RESULTS Lara, Christian

24 S1 p.
article
152 P-15 WAITING LIST FOR LIVER TRANSPLANTATIOS: CLINICAL AND ECONOMIC BURDEN, RETROSPECTIVE STUDY Rodríguez, Santiago

24 S1 p.
article
153 109 TREATMENT PROFILE OF AUTOIMMUNE HEPATITIS IN A BRAZILIAN TERTIARY HOSPITAL Toledo Turano, Camila

24 S1 p.
article
                             153 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands